Protagonist Therapeutics, Inc. · NASDAQ:PTGX

Dapice Joshua J. reported a 9.99% stake in Protagonist Therapeutics, Inc. (Schedule 13G/A)

Event Dec 31, 2025 · Filed Feb 6, 2026

Dapice Joshua J. reported a 9.99% stake in Protagonist Therapeutics, Inc., 6,248,013 shares, as a passive investor on Dec 31, 2025. Filed Feb 6, 2026 (Schedule 13G/A).

Stake
9.99%
Shares
6,248,013
Intent
Passive
What changed
Stake changed
Filed together
31 holders

The filing in full

HolderStakeShares
Farallon Capital Partners, L.P.0.50%283,062
Farallon Capital Institutional Partners, L.P.0.50%290,850
Farallon Capital Institutional Partners II, L.P.0.10%91,421
Farallon Capital Institutional Partners III, L.P.0.10%39,417
Four Crossings Institutional Partners V, L.P.0.10%53,343
Farallon Capital Offshore Investors II, L.P.0.90%565,080
Farallon Capital (AM) Investors, L.P.0.10%36,181
Farallon Capital F5 Master I, L.P.0.20%121,094
Farallon Healthcare Partners Master, L.P.7.60%4,767,564
Farallon Partners, L.L.C.9.80%6,126,919
Farallon Institutional (GP) V, L.L.C.0.10%53,343
Farallon F5 (GP), L.L.C.0.20%121,094
Farallon Healthcare Partners (GP), L.L.C.7.60%4,767,564
Dapice Joshua J.9.99%6,248,013
Dreyfuss, Philip D.9.99%6,248,013
Dunn Hannah E.9.99%6,248,013
Fried, Richard B0%0
Gehani, Varun N.9.99%6,248,013
Giauque, Nicolas9.99%6,248,013
Husen, Avner A.9.99%6,248,013
Kim, David T.9.99%6,248,013
Linn, Michael G.9.99%6,248,013
Luo Patrick (Cheng)9.99%6,248,013
Patel, Rajiv A.0%0
Roberts, Jr., Thomas G.9.99%6,248,013
Saito Edric C.9.99%6,248,013
Seybold, William0%0
Short Daniel S.9.99%6,248,013
Spokes, Andrew J. M.9.99%6,248,013
Warren, John R.9.99%6,248,013
Wehrly, Mark C.9.99%6,248,013

Source

View original at SEC

Related